Here’s What’s Next For Massive Biotech Project

Here’s What’s Next For Massive Biotech Project

October 11, 2017
SAB Biotherapeutics’ Pharm Groundbreaking Highlights Broad Impact

SAB Biotherapeutics’ Pharm Groundbreaking Highlights Broad Impact

October 5, 2017
SAB Biotherapeutics Integrates Operations With New Production Facility

SAB Biotherapeutics Integrates Operations With New Production Facility

August 30, 2017
Pharmaceutical Entrepreneur, William J. Polvino, M.D. Joins SAB Biotherapeutics’ Business Advisory Board

Pharmaceutical Entrepreneur, William J. Polvino, M.D. Joins SAB Biotherapeutics’ Business Advisory Board

August 3, 2017
SAB Biotherapeutics Strengthens Board Of Directors With Appointment Of Biotech Veteran

SAB Biotherapeutics Strengthens Board Of Directors With Appointment Of Biotech Veteran

April 26, 2017
SAB Biotherapeutics Names Christoph Bausch As Chief Science Officer

SAB Biotherapeutics Names Christoph Bausch As Chief Science Officer

April 25, 2017
Cows Engineered With Human Genes Could Stop Our Next Disease Outbreak

Cows Engineered With Human Genes Could Stop Our Next Disease Outbreak

October 4, 2016
Human Antibodies Produced In Cows Might Help Fight Infections Diseases

Human Antibodies Produced In Cows Might Help Fight Infections Diseases

October 2, 2016
SAB Biotherapeutics’ Immunotherapy Proposal Among Top Platform Technology Solutions In Recent WHO Report

SAB Biotherapeutics’ Immunotherapy Proposal Among Top Platform Technology Solutions In Recent WHO Report

September 20, 2016

SAB Biotherapeutics Receives $1.42 Million SBIR Grant To Advance Influenza Treatment

September 7, 2016
SAB Biotherapeutics Announces Contract With BARDA To Advance First MERS Treatment

SAB Biotherapeutics Announces Contract With BARDA To Advance First MERS Treatment

August 24, 2016

Phase I Clinical Trials Underway For First MERS Treatment

August 11, 2016